Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
NLS Pharmaceutics (NLSP) Stock Price & Analysis
155 Followers
NLSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.11 - $1.53
Previous Close$0.2
Volume1.03M
Average Volume (3M)9.78M
Market Cap
$9.33M
Enterprise Value$10.08M
Total Cash (Recent Filing)$908.34K
Total Debt (Recent Filing)$1.66M
Price to Earnings (P/E)―
Beta0.71
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding35,671,780
10 Day Avg. Volume38,552,843
30 Day Avg. Volume9,783,549
Standard Deviation0.26
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.04
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NLS Pharmaceutics News
PremiumCompany Announcements
NLS Pharmaceutics Unveils New Share Purchase Warrant
PremiumCompany Announcements
NLS Pharmaceutics’ Breakthrough in Parkinson’s Research
PremiumCompany Announcements
NLS Pharmaceutics Calls Shareholders’ MeetingPremiumCompany Announcements
NLS Pharmaceutics Receives Nasdaq Compliance Extension
PremiumCompany Announcements
NLS Pharmaceutics Unveils Innovative Narcolepsy TreatmentOwnership Overview
0.00%
Insiders
0.03% Mutual Funds
16.97% Other Institutional Investors
83.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
NLSP FAQ
What was NLS Pharmaceutics’s price range in the past 12 months?
NLS Pharmaceutics lowest stock price was $0.11 and its highest was $1.53 in the past 12 months.
What is NLS Pharmaceutics’s market cap?
Currently, no data Available
When is NLS Pharmaceutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NLS Pharmaceutics’s earnings last quarter?
Currently, no data Available
Is NLS Pharmaceutics overvalued?
According to Wall Street analysts NLS Pharmaceutics’s price is currently Overvalued.
Does NLS Pharmaceutics pay dividends?
NLS Pharmaceutics does not currently pay dividends.
What is NLS Pharmaceutics’s EPS estimate?
NLS Pharmaceutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NLS Pharmaceutics have?
NLS Pharmaceutics has 46,662,968 shares outstanding.
What happened to NLS Pharmaceutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NLS Pharmaceutics?
Currently, no hedge funds are holding shares in NLSP
---
NLS Pharmaceutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.25%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-80.09%
Trailing 12-Months
Company Description
NLS Pharmaceutics
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. The company focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States.
---
NLSP Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---